Extremely significant negative changes in technical position have recently occurred for Catalyst Biosciences Inc (NASDAQ: GYRE): negative upside/downside volume developed, and stock price fell on very heavy volume.
Recent Price Action
Extremely significant negative changes in technical position have recently occurred for Catalyst Biosciences Inc (NASDAQ: GYRE): negative upside/downside volume developed, and stock price fell on very heavy volume.
Current PriceTarget Research Rating
Catalyst Biosciences is currently unrated.
Rating Review
Extremely significant negative changes in technical position have recently occurred for Catalyst Biosciences Inc (NASDAQ: GYRE): negative upside/downside volume developed, and stock price fell on very heavy volume.
Be the first to comment